Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1853169Generated: November 1, 2026

N-(tert-butoxycarbonyl)glycine → (2-{4-[6-(7-cyclopentyl-6-dimethylcarbamoyl-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino)-pyridin-3-yl]-piperazin-1-yl}-2-oxo-ethyl)-carbamic acid tert-butyl ester

https://huagongshe.com/reaction/1853169

Reaction equation

Participants

RoleNameHCIDCharge
ReactantN-(tert-butoxycarbonyl)glycineHCID 78288—
ReactantRibociclib hydrochlorideHCID 67242274—
Product(2-{4-[6-(7-cyclopentyl-6-dimethylcarbamoyl-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino)-pyridin-3-yl]-piperazin-1-yl}-2-oxo-ethyl)-carbamic acid tert-butyl esterHCID 67239391—

Reaction Steps

By repeating procedures described in Example 88, 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide hydrochloride (150 mg, 0.318 mmol), N—BOC-glycine (56 mg, 0.318 mmol) gave a crude product which is purified by SiO2 chromatography, eluting with 0-7% methanol/dichloromethane to give (2-{4-[6-(7-cyclopentyl-6-dimethylcarbamoyl-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino)-pyridin-3-yl]-piperazin-1-yl}-2-oxo-ethyl)-carbamic acid tert-butyl ester which is used directly in the next step.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08962630B2
Source datasetuspto-grants-2015_02
ORD IDord-dedcb8e32a404bd2b29b6edf8094162b
Source noteuspto-grants-2015_02